New Board Member Nominations: The Estée Lauder Companies Inc. announced the nomination of Dana Strong and Annabelle Yu Long for election to its board during the upcoming annual shareholder meeting on November 13, 2025.
Leadership Experience: Both nominees are recognized global executives known for their visionary leadership, strategic capabilities, and proven track records in driving growth and operational excellence in consumer-oriented companies.
Strategic Focus: Their nominations reflect the company's commitment to building a board with deep expertise aligned with key areas such as digital transformation, operational turnaround, Asia-Pacific business issues, direct-to-consumer marketing, and technology.
Official Announcement Note: The original announcement is in the source language and serves as the official version, while translations are provided for reader convenience only.
EL
$104.39+Infinity%1D
Analyst Views on EL
Wall Street analysts forecast EL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EL is 104.06 USD with a low forecast of 70.00 USD and a high forecast of 122.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
Wall Street analysts forecast EL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EL is 104.06 USD with a low forecast of 70.00 USD and a high forecast of 122.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
8 Hold
1 Sell
Moderate Buy
Current: 101.030
Low
70.00
Averages
104.06
High
122.00
Current: 101.030
Low
70.00
Averages
104.06
High
122.00
BofA
NULL -> Strong Buy
upgrade
2025-12-16
New
Reason
BofA
Price Target
2025-12-16
New
upgrade
NULL -> Strong Buy
Reason
BofA analysts added Estee Lauder (EL) to the firm's "US 1 list" while removing AT&T (T). The list represents a collection of BofA's best investment ideas.
BofA
NULL -> Buy
maintain
$120 -> $130
2025-12-16
New
Reason
BofA
Price Target
$120 -> $130
2025-12-16
New
maintain
NULL -> Buy
Reason
BofA raised the firm's price target on Estee Lauder to $130 from $120 and keeps a Buy rating on the shares. Estee Lauder is the analyst's top pick in beauty for 2026 as the firm is encouraged by the "Beauty Reimagined" plan, says the analyst, who cites higher EPS estimates for the firm's raised target. Separately, BofA added Estee Lauder to the firm's "US 1 list," which represents a collection of BofA's best investment ideas.
Citi
NULL -> Buy
upgrade
2025-12-11
Reason
Citi
Price Target
2025-12-11
upgrade
NULL -> Buy
Reason
Citi raised the firm's price target on EssilorLuxottica to EUR 339 from EUR 296 and keeps a Buy rating on the shares.
Goldman Sachs
Buy
maintain
2025-12-05
Reason
Goldman Sachs
Price Target
2025-12-05
maintain
Buy
Reason
Goldman Sachs raised the firm's price target on EssilorLuxottica to EUR 350 from EUR 315 and keeps a Buy rating on the shares. The firm's increased price target is driven by higher organic growth led by Wearables momentum as well as revised discounted cash flow assumptions, the analyst tells investors
About EL
The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its product categories include skin care, makeup, fragrance, hair care and others. Its products are sold in approximately 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD. It is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include lipsticks, lip glosses, mascaras, foundations and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
